Terry F Davies Selected Research

Thyrotropin Receptors (Thyrotropin Receptor)

1/2022	Rescue of thyroid cells from antibody induced cell death via induction of autophagy.
1/2022	Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
1/2020	Graves' disease.
1/2019	A Modifying Autoantigen in Graves' Disease.
1/2019	Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival In Vivo.
1/2016	TSH Receptor Signaling Abrogation by a Novel Small Molecule.
1/2015	New small molecule agonists to the thyrotropin receptor.
12/2013	How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.
1/2013	Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance.
8/2011	The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terry F Davies Research Topics

Disease

30	Graves Disease (Basedow Disease) 01/2022 - 07/2002
19	Hyperthyroidism 01/2022 - 06/2004
14	Thyroid Diseases (Thyroid Disease) 10/2014 - 01/2002
7	Osteoporosis 11/2016 - 04/2006
7	Thyroid Neoplasms (Thyroid Cancer) 06/2015 - 03/2006
7	Bone Resorption 09/2012 - 10/2003
6	Thyroiditis 01/2013 - 10/2006
5	Hypothyroidism 01/2022 - 03/2006
4	Graves Ophthalmopathy 01/2022 - 03/2005
4	Genetic Predisposition to Disease (Genetic Predisposition) 06/2008 - 12/2002
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2012
3	Inflammation (Inflammations) 01/2022 - 01/2013
3	Neoplasms (Cancer) 12/2014 - 01/2011
2	Exophthalmos (Proptosis) 01/2022 - 07/2012
2	Metabolic Bone Diseases (Osteopenia) 11/2016 - 06/2013
2	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 09/2008 - 10/2006
1	Eye Diseases (Eye Disease) 01/2022
1	Diplopia (Double Vision) 01/2022
1	Edema (Dropsy) 01/2022
1	Hypoparathyroidism 01/2020
1	Teratoma (Teratoid Tumor) 01/2020
1	Fetal Diseases (Embryopathy) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Colonic Neoplasms (Colon Cancer) 12/2014
1	Thyroid Nodule (Nodule, Thyroid) 10/2014
1	Euthyroid Goiter 02/2014
1	Infections 12/2012
1	Osteonecrosis (Kienbock's Disease) 12/2011
1	Carcinogenesis 01/2011
1	Carcinoma (Carcinomatosis) 01/2011
1	Melanoma (Melanoma, Malignant) 01/2011
1	Disease Susceptibility (Diathesis) 07/2010
1	Hypogonadism (Hypergonadotropic Hypogonadism) 12/2009
1	Atrial Fibrillation 09/2009
1	Goiter 09/2009
1	Congenital Hypothyroidism (Cretinism) 03/2009
1	Postmenopausal Osteoporosis 11/2007

Drug/Important Bio-Agent (IBA)

25	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2022 - 12/2002
14	Thyroid HormonesIBA 01/2022 - 06/2005
14	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022 - 03/2006
14	AntibodiesIBA 01/2022 - 08/2005
11	AutoantibodiesIBA 01/2022 - 02/2002
7	AntigensIBA 10/2014 - 07/2002
7	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2014 - 03/2006
6	Thyroglobulin FDA Link 01/2013 - 01/2002
5	AutoantigensIBA 01/2019 - 03/2005
5	IodineIBA 02/2014 - 10/2003
4	Monoclonal AntibodiesIBA 01/2022 - 11/2004
3	Hormones (Hormone)IBA 02/2014 - 12/2009
3	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 04/2006 - 07/2002
2	Insulin-Like PeptidesIBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 11/2009
2	Antithyroid Agents (Antithyroid Drugs)IBA 01/2020 - 11/2009
2	Pituitary HormonesIBA 11/2016 - 04/2006
2	Thyroid-Stimulating ImmunoglobulinsIBA 01/2016 - 01/2016
2	LigandsIBA 01/2015 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 09/2007
2	Estrogens (Estrogen)FDA Link 12/2011 - 07/2009
2	NucleotidesIBA 07/2010 - 02/2002
2	HLA-DR Antigens (HLA-DR)IBA 09/2008 - 04/2006
1	teprotumumabIBA 01/2022
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2022
1	Protein-Arginine DeiminasesIBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2016
1	Molecular Probes (Molecular Probe)IBA 01/2015
1	Diphosphonates (Bisphosphonates)IBA 12/2014
1	Messenger RNA (mRNA)IBA 10/2014
1	Lewis X AntigenIBA 03/2014
1	VimentinIBA 01/2014
1	celastrolIBA 01/2014
1	Iodide Peroxidase (Deiodinase)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2012
1	GlucocorticoidsIBA 12/2011
1	FSH Receptors (FSH Receptor)IBA 12/2011
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2011
1	OsteoprotegerinIBA 09/2011
1	Immunoglobulins (Immunoglobulin)IBA 08/2011
1	Oncogene Proteins (Oncogene Protein)IBA 01/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2011
1	MicroRNAs (MicroRNA)IBA 07/2010
1	Long-Acting Thyroid Stimulator (LATS)IBA 12/2009
1	beta-1 Adrenergic Receptors (beta 1 Adrenergic Receptor)IBA 09/2009
1	Muscarinic M2 ReceptorIBA 09/2009
1	Nadolol (Corgard)FDA LinkGeneric 09/2009
1	Atropine FDA LinkGeneric 09/2009
1	Immunoglobulin G (IgG)IBA 09/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2009
1	Thyroid Hormone Receptors alphaIBA 07/2009
1	Follicle Stimulating Hormone (Follitropin)FDA Link 07/2009
1	Biological ProductsIBA 06/2009
1	CTLA-4 AntigenIBA 11/2008
1	Amino Acids FDA Link 09/2008
1	Peptides (Polypeptides)IBA 09/2008

Therapy/Procedure

5	Therapeutics 01/2020 - 11/2007
2	Tissue Expansion 01/2022 - 01/2020
1	Transplantation 01/2020
1	Thyroidectomy 10/2014
1	Drug Therapy (Chemotherapy) 03/2014
1	Decompression 07/2012